Company profile
OPKO Health, Inc.
NASDAQ: OPK · Healthcare · Biotechnology
#195 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
74BFH 62DQ 92GM 67SS 87
v0.1 · 65/100 weight · provisional
↑ filing timeliness, disclosure history · ↓ growth stability, Piotroski F
Methodology →Revenue TTM
$581.1M
Rev growth YoY (TTM)
-15.7%
Net income (FY)
-$225.7M
Employees
2,275
as of 2026-08-10
Market cap
$1.0B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$606.9M$606.9M2025
Net income-$225.7M-$225.7M2025
Operating income-$117.4M-$117.4M2025
Total assets$1.9B$1.9B2025
Liabilities$664.0M$664.0M2025
Equity$1.3B$1.3B2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Service61%
Product26%
Transfer of Intellectual Property and Other13%
By geography
UNITED STATES72%
CHILE10%
IRELAND8%
SPAIN4%
MEXICO4%
Other Countries1%
The read
What is OPKO Health, Inc.’s revenue?
OPKO Health, Inc. booked $606.9M in FY2025 revenue, growing 300% year over year — faster than 91% of Healthcare companies we track, at a -37.2% net margin.
Peers · Healthcare
10x Genomics, Inc.67BAxsome Therapeutics, Inc.59CTG Therapeutics, Inc.72BInsmed Incorporated66BTransMedics Group, Inc.77B+UFP Technologies, Inc.80B+Neighbors
Miami-Dade →Key facts
CEOPhillip Frost
SectorHealthcare
IndustryBiotechnology
HeadquartersMiami, FL
ExchangeNASDAQ: OPK
Employees2,275
IPO date1995-11-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.